Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin: insights from the ARISTOTLE trialShow others and affiliations
2016 (English)Conference paper, Oral presentation with published abstract (Refereed)
Place, publisher, year, edition, pages
2016. Vol. 37, p. 507-507
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:uu:diva-313876ISI: 000383869502353OAI: oai:DiVA.org:uu-313876DiVA, id: diva2:1068399
Conference
Congress of the European-Society-of-Cardiology (ESC), AUG 27-31, 2016, Rome, ITALY
2017-01-252017-01-252017-01-25Bibliographically approved